26 January 2019 - The systematic use of evidence to inform healthcare decisions, particularly health technology assessment, has gained increased recognition. 

HTA has become a standard policy tool for informing decision makers who must manage the entry and use of pharmaceuticals, medical devices, and other technologies (including complex interventions) within health systems, for example, through reimbursement and pricing. 

Despite increasing attention to HTA activities, there has been no attempt to comprehensively synthesise good practices or emerging good practices to support population-based decision-making in recent years. After the identification of some good practices through the release of the ISPOR Guidelines Index in 2013, the ISPOR HTA Council identified a need to more thoroughly review existing guidance. 

The purpose of this effort was to create a basis for capacity building, education, and improved consistency in approaches to HTA-informed decision-making.

Read Value in Health article